Biosensia Ltd.

Industry

  • In Vitro Diagnostics
  • Biotechnology
See more in Biomedtracker

Latest on Biosensia Ltd.

Pink Sheet

Irish Biotech Opsona Adds Two New Corporate VCs In $43M Series C

 
• By John Davis

Ireland’s Opsona Therapeutics Ltd. has raised €33 million ($43 million) in an over-subscribed Series C financing round, with two new corporate VCs - Amgen Ventures and Baxter Ventures - among the

Scrip

Recent Financings of Private Companies (12/2011)

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Andrea Mancini, Maureen Riordan, and Theresa Surprenant

In Vitro Diagnostics Biocartis SA Series C generates €71mm for Biocartis Four-year-old Swiss molecular diagnostics company Biocartis NV has raised €71mm ($96mm) in its Series C financing led by

Medtech Insight

Deals Update

Elsevier’s Strategic Transactions Beth Detuzzi is Editor, Deals Update, for Medtech Insight